These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


243 related items for PubMed ID: 8776736

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intracellular retention of mutant gonadotropin receptors results in loss of hormone binding activity of the follitropin receptor but not of the lutropin/choriogonadotropin receptor.
    Rozzell TG, Wang H, Liu X, Segaloff DL.
    Mol Endocrinol; 1995 Dec; 9(12):1727-36. PubMed ID: 8614409
    [Abstract] [Full Text] [Related]

  • 4. Hormone-binding properties and glycosylation pattern of a recombinant form of the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor expressed in mammalian cells.
    Thomas DM, Segaloff DL.
    Endocrinology; 1994 Nov; 135(5):1902-12. PubMed ID: 7956911
    [Abstract] [Full Text] [Related]

  • 5. The differential binding affinities of the luteinizing hormone (LH)/choriogonadotropin receptor for LH and choriogonadotropin are dictated by different extracellular domain residues.
    Galet C, Ascoli M.
    Mol Endocrinol; 2005 May; 19(5):1263-76. PubMed ID: 15677709
    [Abstract] [Full Text] [Related]

  • 6. Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling.
    Bhowmick N, Huang J, Puett D, Isaacs NW, Lapthorn AJ.
    Mol Endocrinol; 1996 Sep; 10(9):1147-59. PubMed ID: 8885249
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transfected cells express mostly the intracellular precursor of the lutropin/choriogonadotropin receptor but this precursor binds choriogonadotropin with high affinity.
    Fabritz J, Ryan S, Ascoli M.
    Biochemistry; 1998 Jan 13; 37(2):664-72. PubMed ID: 9425089
    [Abstract] [Full Text] [Related]

  • 10. Progressive cytoplasmic tail truncations of the lutropin-choriogonadotropin receptor prevent agonist- or phorbol ester-induced phosphorylation, impair agonist- or phorbol ester-induced desensitization, and enhance agonist-induced receptor down-regulation.
    Wang Z, Hipkin RW, Ascoli M.
    Mol Endocrinol; 1996 Jun 13; 10(6):748-59. PubMed ID: 8776735
    [Abstract] [Full Text] [Related]

  • 11. Phosphorylation of the lutropin/choriogonadotropin receptor facilitates uncoupling of the receptor from adenylyl cyclase and endocytosis of the bound hormone.
    Wang Z, Liu X, Ascoli M.
    Mol Endocrinol; 1997 Feb 13; 11(2):183-92. PubMed ID: 9013765
    [Abstract] [Full Text] [Related]

  • 12. Two mutations of the lutropin/choriogonadotropin receptor that impair signal transduction also interfere with receptor-mediated endocytosis.
    Dhanwada KR, Vijapurkar U, Ascoli M.
    Mol Endocrinol; 1996 May 13; 10(5):544-54. PubMed ID: 8732685
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A dileucine-based motif in the C-terminal tail of the lutropin/choriogonadotropin receptor inhibits endocytosis of the agonist-receptor complex.
    Nakamura K, Ascoli M.
    Mol Pharmacol; 1999 Oct 13; 56(4):728-36. PubMed ID: 10496955
    [Abstract] [Full Text] [Related]

  • 15. Lutropins appear to contact two independent sites in the extracellular domain of their receptors.
    Bernard MP, Myers RV, Moyle WR.
    Biochem J; 1998 Nov 01; 335 ( Pt 3)(Pt 3):611-7. PubMed ID: 9794802
    [Abstract] [Full Text] [Related]

  • 16. Mutations that induce constitutive activation and mutations that impair signal transduction modulate the basal and/or agonist-stimulated internalization of the Lutropin/Choriogonadotropin receptor.
    Min KS, Liu X, Fabritz J, Jaquette J, Abell AN, Ascoli M.
    J Biol Chem; 1998 Dec 25; 273(52):34911-9. PubMed ID: 9857020
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The regulation of the binding affinity of the luteinizing hormone/choriogonadotropin receptor by sodium ions is mediated by a highly conserved aspartate located in the second transmembrane domain of G protein-coupled receptors.
    Quintana J, Wang H, Ascoli M.
    Mol Endocrinol; 1993 Jun 25; 7(6):767-75. PubMed ID: 8395653
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.